Evaluating High Flow Nasal Cannula in Respiratory Care

This chapter examines the rise of high flow nasal cannula (HFNC) in treating acute respiratory failure, comparing its effectiveness to non-invasive ventilation methods like BiPAP. It analyzes a clinical study involving 1,800 patients, discussing demographics, outcomes, limitations, and the implications of the findings. The conversation highlights the cautious interpretation needed for new trial results, particularly in the context of COVID-19 and other patient complexities.